Efficiency of Vaccination With Lysate-loaded Dendritic Cells in Patients With Newly Diagnosed Glioblastoma
Status:
Recruiting
Trial end date:
2023-06-06
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine whether overall survival of newly
diagnosed glioblastoma patients treated with lysate-loaded, mature dendritic cell vaccines as
add-on to the standard of care consisting of resection, radiotherapy with concomitant
temozolomide chemotherapy and subsequent adjuvant temozolomide chemotherapy is superior to
the treatment with the standard of care alone.